UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 Or (Address of principal executive offices, including zip code) (801) 708-6800 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 ...

Health Catalyst, Inc. (NASDAQ:HCAT) Q4 2019 Earnings Conference Call February 27, 2020 5:00 PM ET Company Participants Adam Brown - SVP, IR Daniel Burton - CEO & Director Patrick Nelli - CFO Conference Call Participants Robert Jones - Goldman Sachs Group Anne Samuel - JPMorgan Chase & Co. Ryan Daniels - William Blair & Company Sean Wieland - Piper Sandler & Co. Michael Newshel - Evercore ISI Stanislav Berenshteyn - SunTrust Robinson Humphrey Operator Ladies and gentlemen, thank you for standing by, and welc ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K _______________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 HEALTH CATALYST, INC. (Exact name of registrant as specified in its charter) ___ ...

Health Catalyst, Inc. (NASDAQ:HCAT) Q3 2019 Earnings Conference Call November 12, 2019 5:00 PM ET Company Participants Adam Brown - Senior Vice President, Investor Relations Dan Burton - Chief Executive Officer Patrick Nelli - Chief Financial Officer Conference Call Participants Anne Samuel - JP Morgan Robert Jones - Goldman Sachs Jared Hasse - William Blair Sean Wieland - Piper Jaffray Michael Newshel - Evercore Daniel Grosslight - SVB Leerink Operator Ladies and gentlemen, thank you for standing by and we ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or other jurisdiction of incorporation or organization) Delaware 45-3337483 (I.R.S. Employer Identification Number) For the quarterly period ended September 30, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fr ...

Health Catalyst, Inc. (NASDAQ: HCAT) Q2 2019 Earnings Conference Call August 22, 2019 5:00 PM ET Company Participants Adam Brown - Senior Vice President of Investor Relations Dan Burton - Chief Executive Officer Patrick Nelli - Chief Financial Officer Conference Call Participants Jack Rogoff - Goldman Sachs Anne Samuel - J.P. Morgan Ryan Daniels - William Blair Sean Wieland - Piper Jaffray Susy Tibaldi - Evercore ISI Daniel Grosslight - SVB Leerink Sandy Draper - SunTrust Robinson Humphrey Operator Good day ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 HEALTH CATALYST, INC. (Exact name of registrant as specified in its charter) ...